Fred Hutchinson Cancer Research Center - 2/16

Entry	Author	Date	Location
Adaptive TCR Seeks to Dominate New Industry in Profiling The Immune System	Luke Timmerman	12/13/10	Seattle
Hutch Snaps Up $5.6M at Holiday Gala	Luke Timmerman	12/08/10	Seattle
Sequenta Pockets $13M To Diagnose, Monitor Immune Systems Going Awry	Luke Timmerman	12/08/10	San Francisco
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO	Luke Timmerman	11/12/10	Seattle
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News	Luke Timmerman	11/11/10	Seattle
Report: Ikaria Withdraws IPO, Leaving Arch, Hutch in the Lurch	Luke Timmerman	11/10/10	Seattle
Ikaria IPO Finds So-So Demand, Company Slashes Proposed Offering 38 Percent	Luke Timmerman	11/10/10	Seattle
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan	Luke Timmerman	11/10/10	Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech	Luke Timmerman	11/09/10	Seattle
Steve Davis, the Techie Turned Global Healthie, Gets Dose of Reality at Close Range in India	Luke Timmerman	11/05/10	Seattle
Dendreon’s Plan to Meet Demand, Arch Banks on Ikaria IPO, RF Surgical Leaves No Sponge Behind, & More Seattle-Area Life Sciences News	Luke Timmerman	11/04/10	Seattle
Arch, Hutch Stand to Gain From “Hibernation on Demand” Through Ikaria IPO	Luke Timmerman	11/02/10	Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster	Luke Timmerman	10/26/10	Seattle
A Nobel Laureate’s Stealthy Biotech, Its Japanese Pharma Backer, and the Englishman In Charge	Ryan McBride	10/14/10	Boston
Sage Attracts Bigwigs, Hutch Adds Immunotherapy Center, the Pro-Life Vaccine Firm, & More Seattle-Area Life Sciences News	Luke Timmerman	10/07/10	Seattle
Stanford, UCSD Biologists Take Plunge Into Arpanet-Style Project With Sage Bionetworks	Luke Timmerman	10/06/10	Seattle
Fred Hutch Wins $14M Grant to Establish Cancer Immunotherapy Trial Center	Luke Timmerman	10/04/10	Seattle
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News	Luke Timmerman	09/24/10	San Francisco
Lee Hartwell’s Next Career Move, Swedish’s Social Media Ace, Cell Therapeutics’ Lifeline, & More Seattle-Area Life Sciences News	Luke Timmerman	09/23/10	Seattle
ZymoGenetics Will Be Missed. How Seattle Biotech Can Recover and Thrive	Stewart Lyman	09/21/10	Seattle
Lee Hartwell, at 70, Tackles Personalized Medicine, Education in Latest Career Phase	Luke Timmerman	09/20/10	Seattle
The Future of Humankind Depends on Quality Science Education	Lee Hartwell	09/20/10	National
Leroy Hood & Team Walk into South Lake Union With Plans to Grow	Luke Timmerman	08/18/10	Seattle
Institute for Systems Biology Makes it Official: It’s Moving to Seattle’s South Lake Union	Luke Timmerman	08/18/10	Seattle
Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch	Luke Timmerman	08/02/10	Seattle
Hutch Names Larry Corey as New President, To Build on Hartwell’s Growth Legacy	Luke Timmerman	07/30/10	Seattle
Seattle Genetics’ Dark Horse, Gilead Beats Novartis, Oncothyreon Back in the Saddle, & More Seattle-Area Life Sciences News	Luke Timmerman	06/24/10	Seattle
Presage Biosciences, the Fred Hutch Spinoff, Adds CEO, Angel Bucks, Big Pharma Customers	Luke Timmerman	06/23/10	Seattle
Seattle Genetics Grows Up Fast, Valocor Seeks to Fight Acne, Cell Therapeutics Nabs $21M & More Seattle-Area Life Sciences News	Luke Timmerman	05/27/10	Seattle
Hutch Nabs $10M Computing Grant	Luke Timmerman	05/25/10	Seattle
Page 2 of 6	« previous page · next page »

Entry

Author

Date

Location

Adaptive TCR Seeks to Dominate New Industry in Profiling The Immune System

Luke Timmerman

12/13/10

Seattle

Hutch Snaps Up $5.6M at Holiday Gala

Luke Timmerman

12/08/10

Seattle